Serina Therapeutics annual depreciation and amortization
2017
2018
2019
2020
2022
2023
2024
2025
Serina Therapeutics Depreciation & Amortization Growth & History (SER)
Serina Therapeutics's depreciation and amortization was $100,000 for fiscal 2025.
View full Serina Therapeutics company overviewSerina Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $100,000 | $0 | 0.00% |
| 2024 | 2024-12-31 | $100,000 | $10,000 | +11.11% |
| 2023 | 2023-12-31 | $90,000 | $28,728 | +46.89% |
| 2022 | 2022-12-31 | $61,272 | — | — |
| 2020 | 2020-12-31 | $699,000 | $306,000 | +77.86% |
| 2019 | 2019-12-31 | $393,000 | $335,000 | +577.59% |
| 2018 | 2018-12-31 | $58,000 | −$624,000 | −91.50% |
| 2017 | 2017-12-31 | $682,000 | — | — |
Serina Therapeutics quarterly depreciation and amortization
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18,000 | $2,000 | +12.50% |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q4 2025 | 2025-12-31 | $24,000 | — | — |
| Q3 2025 | 2025-09-30 | $16,000 | −$40,000 | −71.43% |
| Q2 2025 | 2025-06-30 | $16,000 | −$41,000 | −71.93% |
| Q1 2025 | 2025-03-31 | $0 | −$25,000 | — |
| Q3 2024 | 2024-09-30 | $56,000 | $2,000 | +3.70% |
| Q2 2024 | 2024-06-30 | $57,000 | $40,000 | +235.29% |
| Q1 2024 | 2024-03-31 | $25,000 | $12,000 | +92.31% |
| Q3 2023 | 2023-09-30 | $54,000 | — | — |
| Q2 2023 | 2023-06-30 | $17,000 | — | — |
| Q1 2023 | 2023-03-31 | $13,000 | — | — |
| Q1 2021 | 2021-03-31 | $227,000 | $0 | 0.00% |
| Q3 2020 | 2020-09-30 | $230,000 | $113,000 | +96.58% |
| Q2 2020 | 2020-06-30 | $229,000 | $118,000 | +106.31% |
| Q1 2020 | 2020-03-31 | $227,000 | $217,000 | +2170.00% |
| Q3 2019 | 2019-09-30 | $117,000 | −$29,000 | −19.86% |
| Q2 2019 | 2019-06-30 | $111,000 | −$6,000 | −5.13% |
| Q1 2019 | 2019-03-31 | $10,000 | −$112,000 | −91.80% |
| Q3 2018 | 2018-09-30 | $146,000 | — | — |
| Q2 2018 | 2018-06-30 | $117,000 | — | — |
| Q1 2018 | 2018-03-31 | $122,000 | — | — |
Serina Therapeutics depreciation and amortization trends
Over the last five fiscal years, Serina Therapeutics's depreciation and amortization decreased from $699,000 to $100,000, a change of −$599,000. The latest reported quarter, Q2 2026, shows $18,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Serina Therapeutics source filings ↗